Gainers Acer Therapeutics Inc. (NASDAQ: ACER) shares jumped 145% to $1.4850 after Zevra Therapeutics announced it will acquire the company. The transaction will have a total potential value for Acer stockholders of up to $91 million.
U.S. stocks traded mixed toward the end of trading, with the Dow Jones falling more than 100 points on Thursday. The Dow traded down 0.36% to 34,763.44 while the NASDAQ rose 0.26% to 14,056.44. The S&P 500, also fell, dropping, 0.03% to 4,513.47.
Health care stocks were declining late Thursday afternoon with the NYSE Health Care Index falling 0.9% and the Health Care Select Sector SPDR Fund down 1%.
The iShares Biotechnology ETF was.
Relief Therapeutics Announces New Exclusive Definitive License Agreement for OLPRUVA(TM) (ACER-001) with Acer Therapeutics streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.